Form 8-K · Current report
Mondelez International 8-K, filed Jul 28, 2026
- Filed
- CIK
- 0001103982
- Accession no.
- 0001628280-26-050157
Summary
Mondelez International reported second-quarter 2026 net revenues of $9.36 billion, up 4.1% with organic growth of 2.2%, diluted EPS of $1.20 and adjusted EPS of $0.73, down 2.7% in constant currency. The company announced a 4% increase to its quarterly dividend and said it expects at least 2% organic net revenue growth for 2026, with adjusted EPS growth of flat to 5% in constant currency.
Key points
- Net revenues rose 4.1% to $9.36 billion, with organic net revenue up 2.2% and volume/mix up 0.7 pp.
- Diluted EPS was $1.20, up 144.9%, while adjusted EPS was $0.73, down 2.7% on a constant-currency basis.
- The company announced a 4% increase to its quarterly dividend and returned $1.5 billion to shareholders in the first half.
- Full-year 2026 outlook: at least 2% organic net revenue growth, adjusted EPS growth of flat to 5% in constant currency, and free cash flow of about $3 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On July 28, 2026, we issued a press release announcing earnings for the second quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this current report. This information, including Exhibit 99.1, will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and it will not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing. Item 9.01. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.